Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fanconi Anemia | 3 | 2017 | 49 | 1.150 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 4 | 2020 | 12 | 0.960 |
Why?
|
| DNA Damage | 4 | 2020 | 511 | 0.740 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 3 | 2018 | 12 | 0.710 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 90 | 0.670 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2018 | 3 | 0.560 |
Why?
|
| DNA Repair | 2 | 2017 | 571 | 0.510 |
Why?
|
| Flavones | 2 | 2013 | 13 | 0.490 |
Why?
|
| Chondrogenesis | 2 | 2013 | 31 | 0.480 |
Why?
|
| Osteoclasts | 2 | 2013 | 69 | 0.450 |
Why?
|
| Signal Transduction | 6 | 2018 | 4686 | 0.430 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 300 | 0.420 |
Why?
|
| Flavonoids | 2 | 2012 | 84 | 0.420 |
Why?
|
| Metabolomics | 1 | 2018 | 501 | 0.410 |
Why?
|
| NFATC Transcription Factors | 2 | 2013 | 39 | 0.410 |
Why?
|
| Bone Resorption | 2 | 2013 | 52 | 0.400 |
Why?
|
| RANK Ligand | 2 | 2013 | 51 | 0.400 |
Why?
|
| NF-kappa B | 2 | 2013 | 440 | 0.400 |
Why?
|
| Kaempferols | 1 | 2013 | 8 | 0.400 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 86 | 0.390 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 227 | 0.390 |
Why?
|
| Down-Regulation | 2 | 2012 | 645 | 0.360 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 108 | 0.340 |
Why?
|
| Benzylamines | 1 | 2011 | 22 | 0.340 |
Why?
|
| Benzopyrans | 1 | 2011 | 19 | 0.340 |
Why?
|
| Enzyme Activators | 1 | 2011 | 10 | 0.330 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2011 | 31 | 0.330 |
Why?
|
| Neoplasms | 3 | 2018 | 3016 | 0.280 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2008 | 8 | 0.280 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2008 | 20 | 0.280 |
Why?
|
| Androstadienes | 1 | 2008 | 50 | 0.270 |
Why?
|
| Osteosarcoma | 1 | 2011 | 276 | 0.270 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 2323 | 0.260 |
Why?
|
| Politics | 1 | 2007 | 62 | 0.250 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 301 | 0.230 |
Why?
|
| Global Health | 1 | 2007 | 626 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 2026 | 0.180 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1826 | 0.180 |
Why?
|
| Cell Line | 4 | 2013 | 2552 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3748 | 0.150 |
Why?
|
| Genomic Instability | 1 | 2020 | 245 | 0.140 |
Why?
|
| Polyadenylation | 1 | 2018 | 47 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 151 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 587 | 0.130 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 34 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 780 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 265 | 0.120 |
Why?
|
| Cartilage | 2 | 2013 | 52 | 0.120 |
Why?
|
| Proteoglycans | 2 | 2013 | 77 | 0.120 |
Why?
|
| Alkaline Phosphatase | 2 | 2013 | 93 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2013 | 53 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2602 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1928 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 359 | 0.110 |
Why?
|
| Proteins | 1 | 2020 | 1006 | 0.110 |
Why?
|
| Humans | 15 | 2026 | 131163 | 0.110 |
Why?
|
| Animals | 6 | 2018 | 33912 | 0.110 |
Why?
|
| Lipids | 1 | 2018 | 569 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 2596 | 0.100 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 13 | 0.100 |
Why?
|
| Nepal | 2 | 2018 | 25 | 0.100 |
Why?
|
| Collagen Type II | 1 | 2013 | 23 | 0.100 |
Why?
|
| Mice | 5 | 2013 | 18301 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2011 | 576 | 0.090 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 82 | 0.090 |
Why?
|
| KB Cells | 1 | 2012 | 4 | 0.090 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2012 | 23 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2017 | 804 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 58 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2018 | 1077 | 0.090 |
Why?
|
| Mitochondria | 1 | 2017 | 785 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 299 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2012 | 240 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.080 |
Why?
|
| Diterpenes | 1 | 2011 | 33 | 0.080 |
Why?
|
| Biomarkers | 2 | 2018 | 3385 | 0.080 |
Why?
|
| Glycosides | 1 | 2010 | 7 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2010 | 33 | 0.080 |
Why?
|
| Female | 7 | 2026 | 70963 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 1011 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 135 | 0.070 |
Why?
|
| Cell Movement | 1 | 2012 | 876 | 0.070 |
Why?
|
| Fluticasone | 1 | 2008 | 16 | 0.070 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2008 | 14 | 0.070 |
Why?
|
| Defecation | 1 | 2008 | 33 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 853 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 193 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3436 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2020 | 801 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 702 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2026 | 173 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2018 | 749 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1652 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 6196 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 915 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2026 | 711 | 0.050 |
Why?
|
| Protein Stability | 1 | 2020 | 165 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 192 | 0.040 |
Why?
|
| Mutation | 3 | 2018 | 6099 | 0.040 |
Why?
|
| Asthma | 1 | 2008 | 922 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 138 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 59 | 0.030 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2017 | 16 | 0.030 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 17 | 0.030 |
Why?
|
| Male | 5 | 2026 | 64957 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2017 | 147 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 263 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 161 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 383 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 364 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2017 | 175 | 0.030 |
Why?
|
| Adult | 2 | 2026 | 31282 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 336 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 664 | 0.030 |
Why?
|
| Triglycerides | 1 | 2018 | 602 | 0.030 |
Why?
|
| Cholesterol | 1 | 2018 | 539 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 456 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 541 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1133 | 0.030 |
Why?
|
| Middle Aged | 3 | 2026 | 28601 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 604 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 21025 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1319 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 2395 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 1481 | 0.020 |
Why?
|
| Growth Plate | 1 | 2011 | 20 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3359 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2011 | 100 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2011 | 48 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 94 | 0.020 |
Why?
|
| Tibia | 1 | 2011 | 86 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 136 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2026 | 12936 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 11074 | 0.020 |
Why?
|
| Pressure | 1 | 2008 | 117 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 178 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 1155 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2008 | 235 | 0.010 |
Why?
|
| Heart Failure | 1 | 2008 | 2332 | 0.010 |
Why?
|